Clinical Trial

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation. Participant will under go: * Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography Participants will be stratified into three subgroups: * Atrial Functional MR * Atrial Functional TR * Mixed MR \& TR
Protocol Amendment History 1 change
notable Enrollment reduced: 141 -> 60 participants 2026-07-17
Trial Details
NCT Number NCT05920824
Lead Sponsor Barts & The London NHS Trust
Conditions Atrial Fibrillation, Functional Mitral Regurgitation, Functional Tricuspid Regurgitation
Enrollment 60 participants
Start Date 2023-08-23
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-16